An additional dose can increase protection against severe disease, CDA said. Read more at straitstimes.com. Read more at straitstimes.com.

The government’s announcement that GC Biopharma was selected as a Phase 1 (first-stage clinical trial) support company for an ...

The JN.1 Novavax vaccine is an alternative to the LP.8.1 Pfizer-BioNTech and Moderna vaccines that were rolled out in October ...

Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.

With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...

Let’s dive into details regarding each of the evaluated factors, but first, for quick context: With $143 Bil in market ...

The EU document dated 11 November was circulated internally after the EU announced its supply deal with Pfizer and its German partner BioNTech on 11 November ...

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

Fact check - Patients who have been vaccinated against Covid-19 do not need to undergo routine D-dimer testing.

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

The Vaccine Adverse Event Reporting System (VAERS) was established to protect public health. Now it's being used against it.